Massive Bio’s CEO Selin Kurnaz on SCOPE Summit

Massive Bio’s CEO, Dr. Selin Kurnaz, to Attend the Prestigious 2024 SCOPE Summit for Clinical Ops Executives

Selin Kurnaz, PhD, Co-founder and CEO of Massive Bio, will be participating in the prestigious SCOPE Summit for Clinical Ops Executives, taking place from February 11-14, 2024, at Rosen Shingle Creek in Orlando, Florida.

The 15th annual SCOPE Summit promises to be a melting pot of innovation and strategic discussions in clinical trials, with a focus on advancing medical knowledge and improving patient care. The event will feature a series of engaging conference programs, keynote presentations, and networking opportunities with leaders in clinical operations and research.

Selin Kurnaz, Phd, with her extensive experience and contributions to the field, is expected to bring valuable insights and perspectives to the summit. Her participation underscores Massive Bio’s commitment to driving innovation and excellence in clinical trials and digital health. Massive Bio will have an exciting and special announcement before SCOPE and this is an opportunity to reach-out to Massive Bio and get updates during SCOPE. 

The summit is organized by Cambridge Healthtech Institute and is anticipated to draw over 3,300 attendees, including clinical operation experts and newcomers to the field. It is a not-to-miss event for those looking to stay at the forefront of clinical trial innovation.

For more information about the SCOPE Summit, visit: